Loading...
Market
Will E11 Bio partner with a major pharmaceutical company by end of 2024?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Official partnership announcements from E11 Bio or the pharmaceutical company
Story
E11 Bio's Andrew C. Payne Achieves 100x Cost Reduction in Brain Mapping for Curing Disorders with PRISM Technology
Dec 3, 2024, 03:27 PM
E11 Bio has announced a significant advancement in brain mapping technology, achieving a reduction in costs by 100 times. This breakthrough, referred to as PRISM, enables the creation of full brain maps more quickly and efficiently than previously possible. The development is expected to enhance research in connectomics at both human and mouse scales, which is critical for addressing brain disorders, advancing artificial intelligence systems, and simulating human brain functions. The team, led by Andrew C. Payne, has been working diligently on this project, which promises to revolutionize the field of neuroscience and AI.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Pfizer • 25%
Merck • 25%
Roche • 25%
Other • 25%
Yes • 50%
No • 50%
Pfizer • 25%
Merck • 25%
Roche • 25%
Other • 25%
